Skip to main content
OpenTrials
Completed

NCT Number: NCT04778735

Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation

The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver transplantation. The aim of this study is to investigate the overall mortality, morbidity and risk factors for adverse outcomes in pediatric liver transplantation. The patients' records will be retrospectively scanned and the data will be gathered.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Transplantation Bile Duct Diseases Biliary Atresia Biliary Tract Diseases Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Digestive System Abnormalities Digestive System Diseases Liver Diseases Morbidity;Infant Mortality

Age range

0 month–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Memorial Bahçelievler Hospital

Istanbul, 34700, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pediatric patients with liver transplantation (<18 years)

Exclusion criteria

  • Patients with incomplete medical records will be excluded

Treatment and study plan

Liver Transplantation

Procedure

Liver Transplantation is performed under spesific conditions to increase the life time of patients with liver diseases.

Primary outcomes

  1. Survival

    Time frame: 1 minutes

    Patient and graft survival ratios

Secondary outcomes

  1. Perioperative informations

    Time frame: 5 minutes

    Perioperative informations such as blood loss and blood transfusion

  2. Blood Tests

    Time frame: 15 minutes

    Blood markers that evaluated at the pre and post operative phase such as Internation Normalized Ratio (INR), total bilirubin and albumin values.

  3. Postoperative Complications

    Time frame: 5 minutes

    Postoperative Complications such as sepsis or hepatic artery thrombosis

  4. Postoperative informations

    Time frame: 10 minutes

    Postoperative informations such as initial hospital stay, ICU stay or mechanic ventilation time

Sponsors and collaborators

Lead sponsor

Memorial Bahçelievler Hospital

Other

Registry information

Official study title

Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation: A Retrospective Study

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Mar 3, 2021
Registry last updated
Apr 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.